| Year | Firm | Client | Income | Doc |
|---|---|---|---|---|
| 2026 2nd Quarter - Report |
VENABLE LLP | NAF | $10,000 | |
| 2026 2nd Quarter - Report |
VENABLE LLP | WESTAT | $50,000 | |
| 2026 2nd Quarter - Report |
VENABLE LLP | MEDISCA INC. | $20,000 | |
| 2026 AMENDED |
VENABLE LLP | GIFT OF LIFE DONOR PROGRAM | $30,000 | |
| 2026 AMENDED |
VENABLE LLP | GENEOSCOPY | $20,000 | |
| 2026 2nd Quarter - Report |
VENABLE LLP | GIFT OF LIFE DONOR PROGRAM | $30,000 | |
| 2026 2nd Quarter - Report |
VENABLE LLP | GENEOSCOPY | $20,000 | |
| 2026 1st Quarter - Report |
VENABLE LLP | WESTAT | $50,000 | |
| 2026 1st Quarter - Report |
VENABLE LLP | MEDISCA INC. | $20,000 | |
| 2026 1st Quarter - Report |
VENABLE LLP | NAF | $10,000 |